arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

Is It Safe? Introducing LegitScript Healthcare Product Search

Ever wonder if those diet pills you saw advertised online are safe? What about the “100% natural sexual enhancement” supplements? Now there’s a place you can go to find out. LegitScript is pleased to roll out a new search feature (in beta): LegitScript Healthcare Product Search, available on our home page. This is the world’s…

Continue Reading ›

USAToday article references 33 Drugs affiliate

A USAToday article referenced a 33 Drugs marketing affiliate, bestcds.info, in discussing rogue online pharmacies. As we commonly see, “Carl” of bestcds.info claimed that his website was legitimate: “…a representative from one U.K. and Canadian-based online pharmacy, BestCDS.info, maintained its products were legitimate, and said it required faxed prescriptions from consumers. The manager, who said…

Continue Reading ›

Biosimilar and Counterfeit Meds: When Do They Become Dangerous?

Catch the Huffington Post blog by John Horton, LegitScript’s President: Biosimilar and Counterfeit Meds: When do they become dangerous? Biologics are a relatively new type of medicine. Unlike non-biologics such as Lipitor or Nexium, which are from chemicals and can be reproduced into identical “generics,” biologics are made from living organisms (e.g., blood, vampire bat…

Continue Reading ›

Maui News Gets it Wrong on Unapproved Drugs

In an op-ed over the holiday season (Government Protecting Us, December 27, 2010), the Maui News Editorial Board incorrectly argues that the Food and Drug Administration’s (FDA’s) decision to grant exclusivity to the drug company that makes Colcyrs (the only FDA-approved version of colchicine, an anti-gout drug) constitutes “outrageous waste — if not fraud.” Although Maui News’s larger…

Continue Reading ›

Drugs made from vampire bat saliva? Biologics hold promise, but we must put patient safety first

LegitScript’s President, a HuffingtonPost.com contributing blogger, published a blog yesterday entitled “Biologics: Are Unsafe Drugs an ‘Acceptable Risk?’ FDA Should Say No”. The topic is biologics, which are drugs made from living organisms. Examples include Abraxane, a chemical wrapped in human proteins, used as a treatment for breast cancer. (As to the title of this…

Continue Reading ›

Got gout? FDA to colchicine manufacturers: Get FDA-approved

Got Gout? Or Familiar Mediterranean Fever (FMF)? If so, you may have been prescribed oral colchicine, a medication commonly used to treat those conditions. Gout and FMF patients should be aware that the FDA has ordered companies that make, distribute or market that drug to stop doing so, unless they have FDA-approval. This may come…

Continue Reading ›

Unapproved Drugs Mixed With HIV Medications: A Risky Prescription

LegitScript’s President blogged in the Huffington Post today about the risk mixing drugs that are not FDA-approved with HIV medications such as protease inhibitors. As noted in the blog, the danger to HIV patients is: …(that unregulated) drugs, sold by fly-by-night “rogue” Internet pharmacies located overseas, and even by walk-in pharmacies here in the US,…

Continue Reading ›

LegitScript in Huffington Post: Drugs Should Meet 2010 Safety Standards

In the Huffington Post, LegitScript’s President discusses the problem of unapproved drugs – medications that may have been “grandfathered in” to the US drug safety system, but have not been subjected to the same safety and efficacy evaluation as FDA-approved medicines. In describing the problem, the article says: Why are unapproved drugs so readily available…

Continue Reading ›

Two Unapproved Drug Manufacturers File Lawsuit Against FDA

As our readers know, LegitScript has recently been taking a look at another aspect of drug safety: the dispensing of unapproved drugs, both online and offline. In this regard, a recent lawsuit filed by two drug manufacturers against the FDA will be interesting to watch. On their FDA Law Blog, the firm of Hyman, Phelps…

Continue Reading ›

Update: Court Decision Strengthens FDA’s Unapproved Drug Initiative Enforcement

Just a few days after our recent blog about a lawsuit filed against the FDA by two drug manufacturers, the complaint was dismissed in federal court. At its heart, the lawsuit challenged the FDA’s authority in two respects. First, the lawsuit targeted the FDA’s unapproved drug initiative, which seeks to remove unapproved versions of pharmaceutical…

Continue Reading ›

[Webinar]
[Webinar]